CD68 and esophageal squamous cell carcinoma: Therefore, we conducted a comprehensive analysis to investigate the association between TAMS (CD68+, CD163+ or CD204+) and survival outcomes (OS or DFS) in ESCC through pooling data from 2,502 patients who underwent surgery.